| Name | Title | Contact Details |
|---|
ManyChat empowers businesses to create Facebook Messenger bots for marketing, sales, and support, helping to grow ROI and revenue.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Relocity delivers high-touch destination services on-demand by connecting transferring employees with a local personal host via a mobile app.
Quzara is a cybersecurity firm specializing in compliance advisory, cloud security, managed detection and response (MDR), and security operations.
Red Pages, The is a Thornhill, ON-based company in the Software & Internet sector.